NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV 1) - ANVISA Registration 80146502221

Access comprehensive regulatory information for NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV 1) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80146502221 and manufactured by manufacturer not specified. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until Sep 02, 2029.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including CEPHEID AB, ALTONA DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80146502221
2 Related Devices
Registration Details
ANVISA Registration Number: 80146502221
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

80146502221

25351281503201935

56998701000116

Company Information

Dates and Status

Sep 02, 2019

02/09/2029

09/18/2025 19:00:01

Registration Details

80146502221

25351281503201935

56998701000116

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Sep 02, 2019

02/09/2029

09/18/2025 19:00:01